Rare-earth scintillating nanoparticles for X-ray induced photodynamic therapy

  • Tianzi Zhang
  • , Haonan Zheng
  • , Fang Zhang
  • , Chengchao Chu
  • , Taoyu Liao
  • , Lina Xie
  • , Gang Liu
  • , Wen Cai

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

Recently, X-ray induced photodynamic therapy (X-PDT) has attracted wide attention in the field of deep-seated cancer treatment. Rare-earth scintillating nanoparticles (rare-earth ScNPs), a class of rare-earth compound nanoparticles, have X-ray excited optical luminescence (XEOL) characteristic and adjustable emission wavelengths, rendering them ideal X-ray energy converters in X-PDT of deep-seated cancer. However, more detailed and systematic X-PDT research based on rare-earth ScNPs should be conducted ahead of their clinical applications. This review focused on the research progress of rare-earth ScNPs-constructed nanoplatform in X-PDT with the challenges and prospects for rare-earth ScNPs-based X-PDT being discussed as well.

Original languageEnglish
Article number119862
JournalJournal of Luminescence
Volume261
DOIs
StatePublished - Sep 2023

Keywords

  • Bio-imaging
  • Deep-seated cancer
  • Photosensitizer
  • Rare-earth scintillating nanoparticles (rare-earth ScNPs)
  • X-ray induced photodynamic therapy (X-PDT)

Fingerprint

Dive into the research topics of 'Rare-earth scintillating nanoparticles for X-ray induced photodynamic therapy'. Together they form a unique fingerprint.

Cite this